Event Group
Event Groups are part of the Adverse Events Module within the Results Section. They provide a way to organize and summarize adverse event data by grouping related events together.
Each Event Group typically represents a category or class of adverse events and includes statistical information such as the number of participants affected and at risk for different event types: deaths, serious events, and other events.
Event Group path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Group
Event Group
Ignite Creation Date:
2025-12-25 @ 3:13 AM
Ignite Modification Date:
2025-12-26 @ 1:52 AM
NCT ID:
NCT01844505
Group ID:
EG001
Title:
Nivolumab + Ipilimumab
Description:
Nivolumab 1 mg/kg IV combined with Ipilimumab 3 mg/kg IV once every 3 weeks (Q3W) for 4 doses followed by nivolumab 3 mg/kg IV Q2W until disease progression or unacceptable toxicity
Deaths Number Affected:
173
Deaths Number At Risk:
None
Serious Number Affected:
249
Serious Number At Risk:
313
Other Number Affected:
302
Other Number At Risk:
313
Study:
NCT01844505
Results Section:
NCT01844505
Adverse Events Module:
NCT01844505